1 – 10 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells
- Contribution to journal › Article
-
Mark
Picornavirus May Be Linked to Parkinson’s Disease through Viral Antigen in Dopamine-Containing Neurons of Substantia Nigra
- Contribution to journal › Article
-
Mark
Inflammatory Animal Models of Parkinson's Disease
- Contribution to journal › Scientific review
- 2020
-
Mark
Optimization of production and transgene expression of a retrogradely transported pseudotyped lentiviral vector
- Contribution to journal › Article
- 2018
-
Mark
Shifted dynamic interactions between subcortical nuclei and inferior frontal gyri during response preparation in persistent developmental stuttering
- Contribution to journal › Article
- 2017
-
Mark
Toxic effects of human and rodent variants of alpha-synuclein in vivo
- Contribution to journal › Article
-
Mark
PBB3 Imaging in Parkinsonian disorders: Evidence for binding to abnormally aggregated proteins in addition to tau proteins
(2017) 21st International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 32(Suppl 2). p.585-587
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
Pathogenic effects of alpha-synuclein: modifications and toxicity
(2016)
- Thesis › Doctoral thesis (compilation)
- 2014
-
Mark
Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease
- Contribution to journal › Article
- 2013
-
Mark
LAMP2A as a therapeutic target in Parkinson disease
- Contribution to journal › Debate/Note/Editorial
